Correlation Between Effector Therapeutics and Apollomics

Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Apollomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Apollomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Effector Therapeutics and Apollomics Class A, you can compare the effects of market volatilities on Effector Therapeutics and Apollomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Apollomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Apollomics.

Diversification Opportunities for Effector Therapeutics and Apollomics

0.08

Correlation Coefficient

Effector Therapeutics  Apollomics

Significant diversification

The 3 months correlation between Effector and Apollomics is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Apollomics Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollomics Class A and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Apollomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollomics Class A has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Apollomics go up and down completely randomly.

Pair Corralation between Effector Therapeutics and Apollomics

If you would invest  1,200  in Apollomics Class A on August 30, 2024 and sell it today you would lose (384.00) from holding Apollomics Class A or give up 32.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Effector Therapeutics  vs.  Apollomics Class A

Effector Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Effector Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Apollomics Class A

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apollomics Class A has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very uncertain essential indicators, Apollomics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Effector Therapeutics and Apollomics

The main advantage of trading using opposite Effector Therapeutics and Apollomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Apollomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will offset losses from the drop in Apollomics' long position.

The idea behind Effector Therapeutics and Apollomics Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.